Effects of different doses of long-acting growth hormone in treating children with growth hormone deficiency

胰岛素 内分泌学 激素 医学 分泌物 内科学 神经递质 小岛 中枢神经系统
作者
Wei Xia,Ting Wang,Jia‐Yan Pan
出处
期刊:World Journal of Clinical Cases [Baishideng Publishing Group]
卷期号:11 (28): 6715-6724 被引量:1
标识
DOI:10.12998/wjcc.v11.i28.6715
摘要

With the improvement of economy and living standards, the attention paid to short stature in children has been increasingly highlighted. Numerous causes can lead to short stature in children, among which growth hormone deficiency (GHD) is a significant factor.To investigate the long-term efficacy and safety of different doses of long-acting polyethylene glycol recombinant human growth hormone (PEG-rhGH) in the treatment of GHD in children.We selected 44 pediatric patients diagnosed with GHD who were treated at Wuhu First People's Hospital from 2014 to 2018. Total 23 patients were administered a high dose of long-acting PEG-rhGH at 0.2 mg/kg subcutaneously each week, forming the high-dose group. Meanwhile, 21 patients were given a lower dose of long-acting PEG-rhGH at 0.14 mg/kg subcutaneously each week, establishing the low-dose Group. The total treatment period was 2 years, during which we monitored the patients' height, annual growth velocity (GV), height standard deviation score (HtSDS), chronological age (CA), bone age (BA), and serum levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor-binding protein-3 (IGFBP-3) before treatment and at 6 mo, 1 year, and 2 years after treatment initiation. We also monitored thyroid function, fasting plasma glucose, fasting insulin, and other side effects. Furthermore, we calculated the homeostatic model assessment for insulin resistance.After 1 year of treatment, the GV, HtSDS, IGF-1, BA, and IGFBP-3 in both groups significantly improved compared to the pre-treatment levels (P < 0.05). Moreover, when comparing GV, HtSDS, IGF-1, BA, and IGFBP-3 between the two groups, there were no statistically significant differences either before or after the treatment (P > 0.05). During the treatment intervals of 0-1.0 years and 1.0-2.0 years, both patient groups experienced a slowdown in GV and a decline in HtSDS improvement (P < 0.05).The use of PEG-rhGH in treating GHD patients was confirmed to be effective, with similar outcomes observed in both the high-dose group and low-dose groups, and no significant differences in the main side effects.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
夕拾发布了新的文献求助10
1秒前
Owen应助聪慧小霜采纳,获得10
2秒前
Hello应助聪慧小霜采纳,获得10
2秒前
思源应助聪慧小霜采纳,获得10
2秒前
所所应助聪慧小霜采纳,获得10
2秒前
Lucas应助聪慧小霜采纳,获得10
2秒前
言亦云应助聪慧小霜采纳,获得30
2秒前
3秒前
所所应助yuyu采纳,获得10
5秒前
云海老完成签到,获得积分10
6秒前
jimskylxk完成签到,获得积分10
6秒前
Joker完成签到,获得积分20
6秒前
研友_VZG7GZ应助聪慧小霜采纳,获得10
7秒前
ding应助聪慧小霜采纳,获得10
8秒前
情怀应助聪慧小霜采纳,获得30
8秒前
可爱的函函应助聪慧小霜采纳,获得10
8秒前
8秒前
酷波er应助聪慧小霜采纳,获得10
8秒前
无花果应助聪慧小霜采纳,获得30
8秒前
丘比特应助聪慧小霜采纳,获得10
8秒前
乐乐应助聪慧小霜采纳,获得10
8秒前
善学以致用应助聪慧小霜采纳,获得10
8秒前
Jasper应助聪慧小霜采纳,获得30
8秒前
U2完成签到,获得积分10
9秒前
9秒前
smottom应助puzhongjiMiQ采纳,获得10
10秒前
天天快乐应助puzhongjiMiQ采纳,获得10
10秒前
王鹏飞应助puzhongjiMiQ采纳,获得10
10秒前
JamesPei应助puzhongjiMiQ采纳,获得10
10秒前
万能图书馆应助puzhongjiMiQ采纳,获得10
10秒前
王鹏飞应助puzhongjiMiQ采纳,获得10
10秒前
王鹏飞应助puzhongjiMiQ采纳,获得10
10秒前
张童鞋完成签到 ,获得积分10
11秒前
11秒前
Albertxkcj发布了新的文献求助10
13秒前
Jero完成签到 ,获得积分10
13秒前
程程程发布了新的文献求助10
13秒前
KKKKKKK完成签到 ,获得积分10
16秒前
北譩完成签到,获得积分10
18秒前
共享精神应助聪慧小霜采纳,获得10
18秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969557
求助须知:如何正确求助?哪些是违规求助? 3514377
关于积分的说明 11173836
捐赠科研通 3249692
什么是DOI,文献DOI怎么找? 1794979
邀请新用户注册赠送积分活动 875537
科研通“疑难数据库(出版商)”最低求助积分说明 804836